Skip to main content

Genie Energy Ltd.

For the period ended Mar 31, 2025. Filed May 9, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 9, 2025

GNE$17.72+6.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUART ERLY PERIOD ENDED March 31, 2025

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number:1-35327

(Exact Name of Registrant as Specified in its Charter)

Delaware45-2069276
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
520 Broad Street, Newark, New Jersey07102
(Address of principal executive offices)(Zip Code)

(973)438-3500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b)-2 of the Exchange Act:

Title of each ClassTrading SymbolName of exchange of which registered
Class B common stock, par value $0.01 per shareGNENew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Inter active Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12 b-2 of the Exchange Act.

Large accelerated filer☐Accelerated filer☒
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12 b-2 of the Exchange Act.): Yes ☐ No ☒

As of May 7, 2025, the registrant had the following shares outstanding:

Class A common stock, $0.01 par value:1,574,326 shares
Class B common stock, $0.01 par value:25,271,361 shares (excluding 4,051,966 treasury shares)

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION1
Item 1.Financial Statements (Unaudited)1
CONSOLIDATED BALANCE SHEETS1
CONSOLIDATED STATEMENTS OF OPERATIONS2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME3
CONSOLIDATED STATEMENTS OF EQUITY4
CONSOLIDATED STATEMENTS OF CASH FLOWS6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS7
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations36
Item 3Quantitative and Qualitative Disclosures About Market Risks51
Item 4Controls and Procedures51
PART II. OTHER INFORMATION52
Item 1.Legal Proceedings52
Item 1A.Risk Factors52
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds52
Item 3.Defaults upon Senior Securities52
Item 4.Mine Safety Disclosures52
Item 5.Other Information52
Item 6.Exhibits53
SIGNATURES54

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.